EANS-Adhoc: Semperit AG Holding
Semperit postpones publication of the interim
Group report for third quarter: examination of a potential impairment loss at
Sempermed
-------------------------------------------------------------------------------- Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Quarterly Report 13.11.2019 Vienna - Austria, 13 November 2019 - Based on the current insights of the Executive Board of the Semperit AG Holding into the competitive environment of the medical business, a significant impairment loss might occur in the Medical Sector (Sempermed segment). The publication of the interim Group report as of 30 September 2019, which was planned for 21 November 2019, will be postponed; the new date will be announced separately. On 21 November 2019, a shortened reporting will be presented. Further inquiry note: Monika Riedel Director Group Communications & Sustainability +43 676 8715 8620 monika.riedel@semperitgroup.com Judit Helenyi Head of Investor Relations +43 676 8715 8310 judit.helenyi@semperitgroup.com end of announcement euro adhoc --------------------------------------------------------------------------------
issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-310
FAX: +43 1 79 777-602
mail: judit.helenyi@semperitgroup.com
WWW: www.semperitgroup.com
ISIN: AT0000785555
indexes: ATX PRIME, WBI, ATX GP
stockmarkets: Wien
language: English
Original content of: Semperit AG Holding, transmitted by news aktuell